Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Friedman, M. O'Donnell, D. Legarda-Addison, Aylwin Ng, Washington Cárdenas, J. Yount, T. Moran, C. Basler, A. Komuro, C. Horvath, R. Xavier, A. Ting (2008)
The tumour suppressor CYLD is a negative regulator of RIG‐I‐mediated antiviral responseEMBO reports, 9
H. Jono, J. Lim, Lin-Feng Chen, Haidong Xu, Eirini Trompouki, Z. Pan, G. Mosialos, Jian-Dong Li (2004)
NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κBJournal of Biological Chemistry, 279
H Yoshida, H Jono, H Kai, JD Li (2005)
The tumor suppressor CYLD acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 and TRAF7J Biol Chem, 280
M. Lenardo, U. Siebenlist (1994)
Bcl-3-mediated nuclear regulation of the NF-kappa B trans-activating factor.Immunology today, 15 4
Jun Zhang, B. Stirling, Stéphane Temmerman, Chi Ma, I. Fuss, J. Derry, Ashish Jain (2006)
Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.The Journal of clinical investigation, 116 11
V. Buffrénil, A. Quilhac (2008)
Bone RemodelingVertebrate Skeletal Histology and Paleohistology
W. Jin, William Reiley, Andrew Lee, Ato Wright, Xuefeng Wu, Minying Zhang, Shao-Cong Sun (2007)
Deubiquitinating Enzyme CYLD Regulates the Peripheral Development and Naive Phenotype Maintenance of B Cells*♦Journal of Biological Chemistry, 282
H. Yoshida, H. Jono, H. Kai, Jian-Dong Li (2005)
The Tumor Suppressor Cylindromatosis (CYLD) Acts as a Negative Regulator for Toll-like Receptor 2 Signaling via Negative Cross-talk with TRAF6 and TRAF7*Journal of Biological Chemistry, 280
Chuan-Jin Wu, D. Conze, Tao Li, S. Srinivasula, J. Ashwell (2006)
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activationNature Cell Biology, 8
N. Hövelmeyer, F. Wunderlich, R. Massoumi, C. Jakobsen, Jian Song, Jian Song, M. Wörns, Carsten Merkwirth, A. Kovalenko, M. Aumailley, D. Strand, J. Brüning, P. Galle, D. Wallach, R. Fässler, A. Waisman (2007)
Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLDThe Journal of Experimental Medicine, 204
Kohei Saito, T. Kigawa, S. Koshiba, Kazuo Sato, Y. Matsuo, A. Sakamoto, T. Takagi, M. Shirouzu, T. Yabuki, Emi Nunokawa, Eiko Seki, T. Matsuda, M. Aoki, Yukako Miyata, N. Hirakawa, M. Inoue, T. Terada, T. Nagase, R. Kikuno, M. Nakayama, O. Ohara, A. Tanaka, S. Yokoyama (2004)
The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma.Structure, 12 9
I. Rodríguez, C. Ody, K. Araki, I. Garcia, P. Vassalli (1997)
An early and massive wave of germinal cell apoptosis is required for the development of functional spermatogenesisThe EMBO Journal, 16
M. Petronczki, P. Lénárt, J. Peters (2008)
Polo on the Rise-from Mitotic Entry to Cytokinesis with Plk1.Developmental cell, 14 5
Jiabin An, Deqiong Mo, Huiren Liu, M. Veena, E. Srivatsan, R. Massoumi, M. Rettig (2008)
Inactivation of the CYLD deubiquitinase by HPV E6 mediates hypoxia-induced NF-kappaB activation.Cancer cell, 14 5
H. Jono, J. Lim, Lin-Feng Chen, Haidong Xu, Eirini Trompouki, Z. Pan, G. Mosialos, Jian-Dong Li (2004)
NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway.The Journal of biological chemistry, 279 35
F. Stegmeier, M. Sowa, G. Nalepa, S. Gygi, J. Harper, S. Elledge (2007)
The tumor suppressor CYLD regulates entry into mitosisProceedings of the National Academy of Sciences, 104
Shao-Cong Sun, S. Ley (2008)
New insights into NF-kappaB regulation and function.Trends in immunology, 29 10
R. Massoumi, Katarzyna Chmielarska, Katharina Hennecke, A. Pfeifer, R. Fässler (2006)
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB SignalingCell, 125
A Hershko, A Ciechanover (1998)
The ubiquitin systemAnnu Rev Biochem, 67
Honglin Zhou, I. Wertz, K. O’Rourke, M. Ultsch, S. Seshagiri, M. Eby, Wei Xiao, V. Dixit (2004)
Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO.Nature, 427 6970
S. Saggar, K Chernoff, S. Lodha, L. Horev, S. Kohl, R Honjo, H Brandt, K. Hartmann, J Celebi (2008)
CYLD mutations in familial skin appendage tumoursJournal of Medical Genetics, 45
A. Rao (2003)
Faculty Opinions recommendation of CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
DM de Kretser, KL Loveland, A Meinhardt, D Simorangkir, N Wreford (1998)
SpermatogenesisHum Reprod, 13
R. Layfield, Lynne Hocking (2004)
SQSTM1 and Paget’s Disease of BoneCalcified Tissue International, 75
Sebastian Wagner, I. Carpentier, V. Rogov, Marja Kreike, F. Ikeda, Frank Löhr, C. Wu, J. Ashwell, Volker Dötsch, I. Dikič, Rudi Beyaert (2008)
Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteinsOncogene, 27
J. Ting (2004)
Faculty Opinions recommendation of De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
Y. Hirai, Y. Kawamata, N. Takeshima, R. Furuta, T. Kitagawa, T. Kawaguchi, K. Hasumi, S. Sugai, T. Noda (2004)
Conventional and array-based comparative genomic hybridization analyses of novel cell lines harboring HPV18 from glassy cell carcinoma of the uterine cervix.International journal of oncology, 24 4
H. Iha, J. Péloponèse, L. Verstrepen, G. Zapart, F. Ikeda, C. Smith, M. Starost, Venkat Yedavalli, K. Heyninck, I. Dikič, R. Beyaert, K. Jeang (2008)
Inflammatory cardiac valvulitis in TAX1BP1‐deficient mice through selective NF‐κB activationThe EMBO Journal, 27
Gilles Courtois (2008)
Tumor suppressor CYLD: negative regulation of NF-κB signaling and moreCellular and Molecular Life Sciences, 65
Hongxiu Li, Masayuki Kobayashi, M. Blonska, Y. You, Xin Lin (2006)
Ubiquitination of RIP Is Required for Tumor Necrosis Factor α-induced NF-κB Activation*Journal of Biological Chemistry, 281
R. Massoumi, R. Paus (2007)
Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth controlBioEssays, 29
A. Kovalenko, Christine Chable‐Bessia, G. Cantarella, A. Israël, D. Wallach, G. Courtois (2003)
The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitinationNature, 424
L Wang, F Du, X Wang (2008)
TNF-alpha induces two distinct caspase-8 activation pathwaysCell, 133
Y. Takami, H. Nakagami, R. Morishita, T. Katsuya, H. Hayashi, M. Mori, H. Koriyama, Yoshichika Baba, O. Yasuda, H. Rakugi, T. Ogihara, Y. Kaneda (2008)
Potential role of CYLD (Cylindromatosis) as a deubiquitinating enzyme in vascular cells.The American journal of pathology, 172 3
Zhijian Chen (2005)
Ubiquitin signalling in the NF-kappaB pathway.Nature cell biology, 7 8
M. Wooten, T. Geetha, J. Babu, M. Seibenhener, Junmin Peng, N. Cox, M. Diaz-Meco, J. Moscat (2008)
Essential Role of Sequestosome 1/p62 in Regulating Accumulation of Lys63-ubiquitinated Proteins*Journal of Biological Chemistry, 283
M. Walsh, Gregory Kim, Paul Maurizio, Elizabeth Molnar, Yongwon Choi (2008)
TRAF6 Autoubiquitination-Independent Activation of the NFκB and MAPK Pathways in Response to IL-1 and RANKLPLoS ONE, 3
J. Keats, R. Fonseca, M. Chesi, R. Schop, A. Baker, W. Chng, S. Wier, R. Tiedemann, C. Shi, M. Sebag, E. Braggio, T. Henry, Yuan-Xiao Zhu, Homer Fogle, T. Price-Troska, G. Ahmann, Catherine Mancini, L. Brents, Shaji Kumar, P. Greipp, A. Dispenzieri, B. Bryant, G. Mulligan, L. Bruhn, M. Barrett, R. Valdez, Jeff Trent, A. Stewart, J. Carpten, P. Bergsagel (2007)
Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.Cancer cell, 12 2
D. Komander, C. Lord, Hartmut Scheel, S. Swift, K. Hofmann, A. Ashworth, D. Barford (2008)
The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module.Molecular cell, 29 4
J. Lim, H. Jono, Tomoaki Koga, C. Woo, H. Ishinaga, P. Bourne, Hao-wen Xu, U. Ha, Haidong Xu, Jian-Dong Li (2007)
Tumor Suppressor CYLD Acts as a Negative Regulator for Non-Typeable Haemophilus influenza-Induced Inflammation in the Middle Ear and Lung of MicePLoS ONE, 2
J. Lim, B. Stirling, J. Derry, Tomoaki Koga, H. Jono, C. Woo, Hao-wen Xu, P. Bourne, U. Ha, H. Ishinaga, Haidong Xu, A. Andalibi, Xin-Hua Feng, Hong-guang Zhu, Yu-xian Huang, Wenhong Zhang, X. Weng, Chen Yan, Z. Yin, D. Briles, R. Davis, R. Flavell, Jian-Dong Li (2007)
Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.Immunity, 27 2
M. Sudol, Henry Chen, C. Bougeret, A. Einbond, P. Bork (1995)
Characterization of a novel protein‐binding module — the WW domainFEBS Letters, 369
B. Lamothe, William Webster, Ambily Gopinathan, Arnaud Besse, Alejandro Campos, B. Darnay (2007)
TRAF6 ubiquitin ligase is essential for RANKL signaling and osteoclast differentiation.Biochemical and biophysical research communications, 359 4
Kiichiro Hashimoto, N. Mori, T. Tamesa, Toshimasa Okada, S. Kawauchi, A. Oga, T. Furuya, A. Tangoku, M. Oka, K. Sasaki (2004)
Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGHModern Pathology, 17
Chuan-Jin Wu, D. Conze, Tao Li, S. Srinivasula, J. Ashwell (2006)
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].Nature cell biology, 8 4
S. Nijman, M. Luna-Vargas, A. Velds, T. Brummelkamp, A. Dirac, T. Sixma, R. Bernards (2005)
A Genomic and Functional Inventory of Deubiquitinating EnzymesCell, 123
C. Print, K. Loveland (2000)
Germ cell suicide: new insights into apoptosis during spermatogenesisBioEssays, 22
M. Steinmetz, A. Akhmanova (2008)
Capturing protein tails by CAP-Gly domains.Trends in biochemical sciences, 33 11
Shao-Cong Sun (2008)
Deubiquitylation and regulation of the immune responseNature Reviews Immunology, 8
D. Lee, M. Grossman, P. Schneiderman, J. Celebi (2005)
Genetics of skin appendage neoplasms and related syndromesJournal of Medical Genetics, 42
S. Li (2005)
Specificity and versatility of SH3 and other proline-recognition domains: structural basis and implications for cellular signal transduction.The Biochemical journal, 390 Pt 3
S. Oshima, Emre Turer, Joseph Callahan, Sophia Chai, Rommel Advincula, Julio Barrera, N. Shifrin, Bettina Lee, B. Yen, B. Malynn, A. Ma (2009)
ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic developmentNature, 458
M. Seibenhener, J. Babu, T. Geetha, H. Wong, N. Krishna, M. Wooten (2004)
Sequestosome 1/p62 Is a Polyubiquitin Chain Binding Protein Involved in Ubiquitin Proteasome DegradationMolecular and Cellular Biology, 24
Jinmin Gao, L. Huo, Xiaoou Sun, Min Liu, Dengwen Li, Jin-Tang Dong, Jun Zhou (2008)
The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration*Journal of Biological Chemistry, 283
S Wagner, I Carpentier, V Rogov, M Kreike, F Ikeda, CJ Wu (2008)
Ubiquitin binding mediates the NF-kB inhibitory potential of ABINsOncogene, 27
K. Heyninck, R. Beyaert (2005)
A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.Trends in biochemical sciences, 30 1
S. Beaudenon, J. Huibregtse (2007)
HPV E6, E6AP and cervical cancerBMC Biochemistry, 9
P. Ströbel, A. Zettl, Z. Ren, P. Starostik, H. Riedmiller, S. Störkel, H. Müller-hermelink, A. Marx (2002)
Spiradenocylindroma of the Kidney: Clinical and Genetic Findings Suggesting a Role of Somatic Mutation of the CYLD1 Gene in the Oncogenesis of an Unusual Renal NeoplasmThe American Journal of Surgical Pathology, 26
E. Varfolomeev, Tatiana Goncharov, A. Fedorova, Jasmin Dynek, K. Zobel, K. Deshayes, W. Fairbrother, D. Vučić (2008)
c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation*Journal of Biological Chemistry, 283
C. Annunziata, R. Davis, Y. Demchenko, W. Bellamy, Ana Gabrea, F. Zhan, G. Lenz, I. Hanamura, George Wright, Wenming Xiao, S. Dave, E. Hurt, Bruce Tan, Hong Zhao, O. Stephens, M. Santra, David Williams, L. Dang, B. Barlogie, J. Shaughnessy, W. Kuehl, L. Staudt (2007)
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.Cancer cell, 12 2
R. Beyaert, K. Heyninck, S. Huffel (2000)
A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis.Biochemical pharmacology, 60 8
Lynn Fraser (1998)
The modulation of sperm function by fertilization promoting peptide.Human reproduction, 13 Suppl 4
Yun-Cai Liu, J. Penninger, M. Karin (2005)
Immunity by ubiquitylation: a reversible process of modificationNature Reviews. Immunology, 5
Ato Wright, W. Reiley, Mikyoung Chang, W. Jin, Andrew Lee, Minying Zhang, Shao-Cong Sun (2007)
Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.Developmental cell, 13 5
Jessica Hutti, B. Turk, J. Asara, A. Ma, L. Cantley, Derek Abbott (2007)
IκB Kinase β Phosphorylates the K63 Deubiquitinase A20 To Cause Feedback Inhibition of the NF-κB PathwayMolecular and Cellular Biology, 27
A. Rao (2003)
Faculty Opinions recommendation of Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.
D. Boone, Emre Turer, Eric Lee, Regina‐Celeste Ahmad, M. Wheeler, C. Tsui, P. Hurley, Marcia Chien, Sophia Chai, O. Hitotsumatsu, E. McNally, C. Pickart, A. Ma (2004)
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responsesNature Immunology, 5
W. Reiley, Minying Zhang, Shao-Cong Sun (2004)
Negative Regulation of JNK Signaling by the Tumor Suppressor CYLD*Journal of Biological Chemistry, 279
S. Itzkowitz, T. Ullman (2004)
The world isn't flat.Gastrointestinal endoscopy, 60 3
Hongxiu Li, Masayuki Kobayashi, M. Blonska, Y. You, Xin Lin (2006)
Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation.The Journal of biological chemistry, 281 19
Honglin Zhou, I. Wertz, K. O’Rourke, M. Ultsch, S. Seshagiri, M. Eby, Wei Xiao, V. Dixit (2004)
Bcl10 activates the NF-κB pathway through ubiquitination of NEMONature, 427
R. Massoumi, S. Kuphal, Claus Hellerbrand, Bodo Haas, Peter Wild, T. Spruss, Alexander Pfeifer, Reinhard Fässler, A. Bosserhoff (2009)
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanomaThe Journal of Experimental Medicine, 206
B. Lamothe, Alejandro Campos, William Webster, Ambily Gopinathan, L. Hur, B. Darnay (2008)
The RING Domain and First Zinc Finger of TRAF6 Coordinate Signaling by Interleukin-1, Lipopolysaccharide, and RANKL*Journal of Biological Chemistry, 283
D. Conze, Chuan-Jin Wu, James Thomas, Allison Landstrom, J. Ashwell (2008)
Lys63-Linked Polyubiquitination of IRAK-1 Is Required for Interleukin-1 Receptor- and Toll-Like Receptor-Mediated NF-κB ActivationMolecular and Cellular Biology, 28
C. Costello, N. Mah, R. Häsler, P. Rosenstiel, G. Waetzig, Andreas Hahn, T. Lu, Y. Gurbuz, S. Nikolaus, M. Albrecht, J. Hampe, R. Lucius, G. Klöppel, H. Eickhoff, H. Lehrach, Thomas Lengauer, S. Schreiber (2005)
Dissection of the Inflammatory Bowel Disease Transcriptome Using Genome-Wide cDNA MicroarraysPLoS Medicine, 2
W. Reiley, Minying Zhang, Xuefeng Wu, E. Granger, Shao-Cong Sun (2005)
Regulation of the Deubiquitinating Enzyme CYLD by IκB Kinase Gamma-Dependent PhosphorylationMolecular and Cellular Biology, 25
A. Stokes, Clay Wakano, M. Koblan-Huberson, C. Adra, A. Fleig, H. Turner (2006)
TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD.Cellular signalling, 18 10
Eirini Trompouki, E. Hatzivassiliou, Theodore Tsichritzis, H. Farmer, A. Ashworth, G. Mosialos (2003)
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family membersNature, 424
A. Daroszewska, S. Ralston (2006)
Mechanisms of Disease: genetics of Paget's disease of bone and related disordersNature Clinical Practice Rheumatology, 2
Jessica Hutti, B. Turk, J. Asara, A. Ma, L. Cantley, Derek Abbott (2007)
IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway.Molecular and cellular biology, 27 21
M. Lenardo, U. Siebenlist (1994)
Bcl-3-mediated nuclear regulation of the NF-кB trans-activating factorImmunology Today, 15
Minying Zhang, Xuefeng Wu, Andrew Lee, W. Jin, Mikyoung Chang, Ato Wright, T. Imaizumi, Shao-Cong Sun (2008)
Regulation of IκB Kinase-related Kinases and Antiviral Responses by Tumor Suppressor CYLD*Journal of Biological Chemistry, 283
Chee-Kwee Ea, L. Deng, Zong-Ping Xia, Gabriel Pineda, Zhijian Chen (2006)
Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.Molecular cell, 22 2
Zhijian Chen (2005)
Ubiquitin signalling in the NF-κB pathwayNature Cell Biology, 7
(2004)
Tumor suppressor negatively regulates JNK signaling pathway downstream of TNFR members
Chang-Yuan Ni, Zhao-Hui Wu, William Florence, Vrajesh Parekh, M. Arrate, Steven Pierce, B. Schweitzer, L. Kaer, S. Joyce, S. Miyamoto, D. Ballard, E. Oltz (2008)
Cutting Edge: K63-Linked Polyubiquitination of NEMO Modulates TLR Signaling and Inflammation In Vivo1The Journal of Immunology, 180
Li Wang, R. Baiocchi, Sharmistha Pal, G. Mosialos, M. Caligiuri, S. Sif (2005)
The BRG1- and hBRM-Associated Factor BAF57 Induces Apoptosis by Stimulating Expression of the Cylindromatosis Tumor Suppressor GeneMolecular and Cellular Biology, 25
Eric Lee, D. Boone, Sophia Chai, Shon Libby, Marcia Chien, James Lodolce, A. Ma (2000)
Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice.Science, 289 5488
G. Bignell, W. Warren, S. Seal, Meiko Takahashi, E. Rapley, R. Barfoot, H. Green, Carolanne Brown, Patrick Biggs, Sunil Lakhani, Christopher Jones, J. Hansen, E. Blair, B. Hofmann, R. Siebert, G. Turner, D. Evans, C. Schrander‐Stumpel, F. Beemer, A. Ouweland, D. Halley, B. Delpech, M. Cleveland, I. Leigh, J. Leisti, S. Rasmussen, Margaret Wallace, C. Fenske, Piu Banerjee, N. Oiso, R. Chaggar, Samantha Merrett, N. Leonard, M. Huber, D. Hohl, P. Chapman, J. Burn, S. Swift, Anna Smith, A. Ashworth, Michael Stratton (2000)
Identification of the familial cylindromatosis tumour-suppressor geneNature Genetics, 25
Lai Wang, Fenghe Du, Xiaodong Wang (2008)
TNF-α Induces Two Distinct Caspase-8 Activation PathwaysCell, 133
W. Jin, Mikyoung Chang, E. Paul, Geetha Babu, Andrew Lee, W. Reiley, Ato Wright, Minying Zhang, Jun You, Shao-Cong Sun (2008)
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice.The Journal of clinical investigation, 118 5
W Jin, M Chang, EM Paul, G Babu, AJ Lee, WW Reiley (2008)
Deubiquitinating enzyme CYLD regulates RANK signaling and osteoclastogenesisJ Clin Invest, 118
S Ong, Marcy Hackbarth, Linda Degenstein, David Baunoch, J. Anastasi, T. Mckeithan (1998)
Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic miceOncogene, 16
Derek Abbott, A. Wilkins, J. Asara, L. Cantley (2004)
The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMOCurrent Biology, 14
Noula Shembade, Nicole Harhaj, D. Liebl, E. Harhaj (2007)
Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signalingThe EMBO Journal, 26
M. Rutter, B. Saunders, K. Wilkinson, M. Kamm, C. Williams, A. Forbes (2004)
Most dysplasia in ulcerative colitis is visible at colonoscopy.Gastrointestinal endoscopy, 60 3
I. Wertz, K. O’Rourke, Honglin Zhou, M. Eby, L. Aravind, S. Seshagiri, Ping Wu, C. Wiesmann, R. Baker, D. Boone, A. Ma, E. Koonin, V. Dixit (2004)
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signallingNature, 430
T. Brummelkamp, S. Nijman, A. Dirac, R. Bernards (2003)
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κBNature, 424
Tomoaki Koga, J. Lim, H. Jono, U. Ha, Haidong Xu, H. Ishinaga, S. Morino, Xiangbin Xu, C. Yan, H. Kai, Jian-Dong Li (2008)
Tumor Suppressor Cylindromatosis Acts as a Negative Regulator for Streptococcus pneumoniae-induced NFAT Signaling*Journal of Biological Chemistry, 283
J. Lim, U. Ha, C. Woo, Haidong Xu, Jian-Dong Li (2008)
CYLD is a crucial negative regulator of innate immune response in Escherichia coli pneumoniaCellular Microbiology, 10
C. Mauro, F. Pacifico, Alfonso Lavorgna, S. Mellone, Alessio Iannetti, R. Acquaviva, S. Formisano, P. Vito, A. Leonardi (2006)
ABIN-1 Binds to NEMO/IKKγ and Co-operates with A20 in Inhibiting NF-κB*Journal of Biological Chemistry, 281
K. Heyninck, R. Beyaert (2005)
A20 inhibits NF-κB activation by dual ubiquitin-editing functionsTrends in Biochemical Sciences, 30
Noula Shembade, Nicole Harhaj, D. Liebl, E. Harhaj (2007)
Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.The EMBO journal, 26 17
W. Reiley, W. Jin, Andrew Lee, Ato Wright, Xuefeng Wu, E. Tewalt, T. Leonard, C. Norbury, L. Fitzpatrick, Minying Zhang, Shao-Cong Sun (2007)
Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responsesThe Journal of Experimental Medicine, 204
C. Hellerbrand, E. Bumes, F. Bataille, W. Dietmaier, R. Massoumi, A. Bosserhoff (2007)
Reduced expression of CYLD in human colon and hepatocellular carcinomas.Carcinogenesis, 28 1
W. Reiley, Minying Zhang, W. Jin, M. Losiewicz, Keri Donohue, C. Norbury, Shao-Cong Sun (2006)
Regulation of T cell development by the deubiquitinating enzyme CYLDNature Immunology, 7
Alexandre Regamey, D. Hohl, J. Liu, T. Roger, P. Kogerman, R. Toftgård, M. Huber (2003)
The Tumor Suppressor CYLD Interacts with TRIP and Regulates Negatively Nuclear Factor κB Activation by Tumor Necrosis FactorThe Journal of Experimental Medicine, 198
DJ Hadjidakis, I Androulakis (2006)
Bone remodelingAnn NY Acad Sci, 1092
E Varfolomeev, T Goncharov, AV Fedorova, JN Dynek, K Zobel, K Deshayes (2008)
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activationJ Biol Chem, 283
C. Mauro, F. Pacifico, Alfonso Lavorgna, S. Mellone, Alessio Iannetti, R. Acquaviva, S. Formisano, P. Vito, A. Leonardi (2006)
ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.The Journal of biological chemistry, 281 27
M. Jenner, P. Leone, B. Walker, F. Ross, David Johnson, D. Gonzalez, L. Chiecchio, Elisabet Cabanas, G. Dagrada, M. Nightingale, R. Protheroe, David Stockley, M. Else, N. Dickens, N. Cross, F. Davies, G. Morgan (2007)
Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.Blood, 110 9
F. Giancotti (2006)
Faculty Opinions recommendation of Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
Anirban Adhikari, M. Xu, Zhijian Chen, Zhijian Chen (2007)
Ubiquitin-mediated activation of TAK1 and IKKOncogene, 26
Protein ubiquitination is a reversible reaction, in which the ubiquitin chains are deconjugated by a family of deubiquitinases (DUBs). The presence of a large number of DUBs suggests that they likely possess certain levels of substrate selectivity and functional specificity. Indeed, recent studies show that a tumor suppressor DUB, cylindromatosis (CYLD), has a predominant role in the regulation of NF-κB, a transcription factor that promotes cell survival and oncogenesis. NF-κB activation involves attachment of K63-linked ubiquitin chains to its upstream signaling factors, which is thought to facilitate protein–protein interactions in the assembly of signaling complexes. By deconjugating these K63-linked ubiquitin chains, CYLD negatively regulates NF-κB activation, which may contribute to its tumor suppressor function. CYLD also regulates diverse physiological processes, ranging from immune response and inflammation to cell cycle progression, spermatogenesis, and osteoclastogenesis. Interestingly, CYLD itself is subject to different mechanisms of regulation.
Cell Death & Differentiation – Springer Journals
Published: Apr 17, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.